BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 18313880)

  • 1. Recommendations for general surgeons facing incidental peritoneal carcinomatosis of colorectal origin.
    Liberale G; Van Den Eynde M; Hendlisz A; El Nakadi I
    Eur J Surg Oncol; 2008 Jul; 34(7):725-6. PubMed ID: 18313880
    [No Abstract]   [Full Text] [Related]  

  • 2. Results of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis from colorectal cancer.
    Glockzin G; Ghali N; Lang SA; Schlitt HJ; Piso P
    J Surg Oncol; 2009 Sep; 100(4):306-10. PubMed ID: 19697436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hidden opportunities in cytoreductive surgery for peritoneal carcinomatosis of colorectal origin.
    Chang GJ; Lambert LA
    Ann Surg Oncol; 2008 Nov; 15(11):2993-5. PubMed ID: 18787903
    [No Abstract]   [Full Text] [Related]  

  • 4. [New treatment of peritoneal carcinomatosis from colorectal cancer. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy].
    Iversen LH; Rasmussen PC; Laurberg S
    Ugeskr Laeger; 2007 Sep; 169(38):3179-81. PubMed ID: 17910824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of peritoneal carcinomatosis from colorectal cancer with cytoreductive surgery and perioperative intraperitoneal chemotherapy: state of the art and future prospects.
    Di Carlo I; Pulvirenti E; Sparatore F; Toro A; Cordio S
    Surg Oncol; 2007 Dec; 16 Suppl 1():S145-8. PubMed ID: 18023575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis from colorectal and gastrointestinal origin shows acceptable morbidity and high survival.
    Hagendoorn J; van Lammeren G; Boerma D; van der Beek E; Wiezer MJ; van Ramshorst B
    Eur J Surg Oncol; 2009 Aug; 35(8):833-7. PubMed ID: 19019619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Results of cytoreduction followed by HIPEC in carcinomatosis of colorectal origin.
    Verwaal VJ
    Cancer Treat Res; 2007; 134():291-301. PubMed ID: 17633061
    [No Abstract]   [Full Text] [Related]  

  • 8. 8-year follow-up of randomized trial: cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer.
    Verwaal VJ; Bruin S; Boot H; van Slooten G; van Tinteren H
    Ann Surg Oncol; 2008 Sep; 15(9):2426-32. PubMed ID: 18521686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term results of cytoreduction and HIPEC followed by systemic chemotherapy.
    Verwaal VJ
    Cancer J; 2009; 15(3):212-5. PubMed ID: 19556907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An evolving role of perioperative intraperitoneal chemotherapy after cytoreductive surgery for colorectal peritoneal carcinomatosis.
    Yan TD; Sugarbaker PH
    Ann Surg Oncol; 2007 Jul; 14(7):2171-2. PubMed ID: 17453299
    [No Abstract]   [Full Text] [Related]  

  • 11. Conventional surgery and systemic chemotherapy for peritoneal carcinomatosis of colorectal origin: a prospective study.
    Bloemendaal AL; Verwaal VJ; van Ruth S; Boot H; Zoetmulder FA
    Eur J Surg Oncol; 2005 Dec; 31(10):1145-51. PubMed ID: 16084051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The randomized trial of cytoreductive surgery with hyperthermic intraperitoneal chemoperfusion: what it does and does not tell us.
    Levine EA
    Ann Surg Oncol; 2008 Oct; 15(10):2633-5. PubMed ID: 18696161
    [No Abstract]   [Full Text] [Related]  

  • 13. Quantitative intra-operative assessment of peritoneal carcinomatosis - a comparison of three prognostic tools.
    Swellengrebel HA; Zoetmulder FA; Smeenk RM; Antonini N; Verwaal VJ
    Eur J Surg Oncol; 2009 Oct; 35(10):1078-84. PubMed ID: 19285828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytoreductive surgery and perioperative intraperitoneal chemotherapy for colorectal carcinomatosis: if at first you don't succeed...
    Lambert LA; Mansfield PF
    Ann Surg Oncol; 2007 Nov; 14(11):3037-9. PubMed ID: 17726635
    [No Abstract]   [Full Text] [Related]  

  • 15. [Treatment of the peritoneal carcinomatosis by cytoreductive surgery and intraperitoneal hyperthermic chemotherapy (IHPC): postoperative morbidity and mortality and short-term follow-up].
    Minicozzi A; Borzellino G; Momo EN; Segattini C; Pitoni F; Steccanella F; De Manzoni G
    Ann Ital Chir; 2008; 79(4):231-9. PubMed ID: 19093624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytoreductive surgery plus intraperitoneal chemohyperthermia in patients with colorectal cancer at high risk for local-regional recurrence.
    Lefevre JH; Elias DM
    Cancer J; 2009; 15(3):200-3. PubMed ID: 19556905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Indications and patient selection for cytoreductive surgery and perioperative intraperitoneal chemotherapy.
    González-Moreno S; Ortega-Pérez G; González-Bayón L
    J Surg Oncol; 2009 Sep; 100(4):287-92. PubMed ID: 19697424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytoreductive surgery and perioperative intraperitoneal chemotherapy for isolated colorectal peritoneal carcinomatosis: experimental therapy or standard of care?
    Yan TD; Morris DL
    Ann Surg; 2008 Nov; 248(5):829-35. PubMed ID: 18948811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Learning curve in cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
    Moradi BN; Esquivel J
    J Surg Oncol; 2009 Sep; 100(4):293-6. PubMed ID: 19697425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peritoneal carcinomatosis: what can we do about it?
    Shen P; Levine EA; Loggie BW
    J Clin Oncol; 2004 Jan; 22(1):202; author reply 203. PubMed ID: 14701786
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.